A
$ Value
$0
Shares
40,586
Price
$0
Filed
Mar 3
Insider
Name
Keenan Greg
Title
SVP, Chief Medical Officer
CIK
0002044006
Roles
Officer
Transaction Details
Transaction Date
2026-02-27
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
162,518
Footnotes
Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement. | One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.
Filing Info
Keenan Greg's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-06 | AUPH | F | $116K |
| 2026-02-27 | AUPH | A | $0 |
| 2026-02-27 | AUPH | A | $0 |
| 2026-02-02 | AUPH | F | $168K |
| 2025-08-01 | AUPH | ▼ | $210K |
Other Insiders at AUPH (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| TANG KEVIN | $12.7M | — | 2026-03-03 |
|
Greenleaf Peter
Chief Executive Officer
|
— | — | 2026-03-02 |
|
Donley Matthew Maxwell
Chief Operating Officer
|
— | — | 2026-03-02 |
|
Miller Joseph M
Chief Financial Officer
|
— | — | 2026-03-02 |
|
Robertson Stephen P.
EVP, General Counsel
|
— | — | 2026-03-02 |
|
Keenan Greg
SVP, Chief Medical Officer
|
— | — | 2026-03-06 |